C-type lectin receptor DCIR modulates immunity to tuberculosis by sustaining type I interferon signaling in dendritic cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 114, Issue 4, 2017, Pages E540-E549

  Troegeler, Anthony ^a,b   Mercier, Ingrid ^a,b   Cougoule, Céline ^a,b   Pietretti, Danilo ^a,b   Colom, André ^a,b   Duval, Carine ^a,b   Vu Manh, Thien Phong ^c   Capilla, Florence ^d   Poincloux, Renaud ^a,b   Pingris, Karine ^a,b   Nigou, Jérôme ^a,b   Rademann, Jörg ^e   Dalod, Marc ^c   Verreck, Frank A W ^f   Al Saati, Talal ^d   Lugo Villarino, Geanncarlo ^a,b   Lepenies, Bernd ^g   Hudrisier, Denis ^a,b   Neyrolles, Olivier ^a,b  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^d INSERM   (France)

^e FREIE UNIVERSITÄT BERLIN   (Germany)

^f BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^g UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

C type lectin; Inflammation; Tuberculosis

Indexed keywords

C TYPE LECTIN RECEPTOR; DENDRITIC CELL IMMUNORECEPTOR; INTERFERON; INTERLEUKIN 12; LECTIN RECEPTOR; STAT1 PROTEIN; UNCLASSIFIED DRUG; DCIR PROTEIN, MOUSE; LECTIN; STAT1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; IMMUNOMODULATION; INFLAMMATION; LUNG TUBERCULOSIS; LYMPHOCYTE DIFFERENTIATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE; TH1 CELL; ANIMAL; C57BL MOUSE; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; PHOSPHORYLATION; RHESUS MONKEY; SIGNAL TRANSDUCTION; TUBERCULOSIS;

ANIMALS; DENDRITIC CELLS; FEMALE; INTERFERON TYPE I; LECTINS, C-TYPE; MACACA MULATTA; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHORYLATION; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TUBERCULOSIS;

EID: 85010734929     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1613254114     Document Type: Article

References (46)

1. Cooper AM (2009) Cell-mediated immune responses in tuberculosis. Annu Rev Immunol 27:393-422.
2. O'Garra A, et al. (2013) The immune response in tuberculosis. Annu Rev Immunol 31:475-527.
3. Ernst JD (2012) The immunological life cycle of tuberculosis. Nat Rev Immunol 12(8):581-591.
4. Sancho D, Reis e Sousa C (2012) Signaling by myeloid C-type lectin receptors in immunity and homeostasis. Annu Rev Immunol 30:491-529.
5. Bates EE, et al. (1999) APCs express DCIR, a novel C-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motif. J Immunol 163(4):1973-1983.
6. Kerscher B, Willment JA, Brown GD (2013) The Dectin-2 family of C-type lectin-like receptors: an update. Int Immunol 25(5):271-277.
7. Nagae M, et al. (2016) Crystal structure of human dendritic cell inhibitory receptor (DCIR) C-type lectin domain reveals the binding mode with N-glycan. FEBS Lett 590(8):1280-1288.
8. Bloem K, et al. (2014) DCIR interacts with ligands from both endogenous and pathogenic origin. Immunol Lett 158(1-2):33-41.
9. Lambert AA, Gilbert C, Richard M, Beaulieu AD, Tremblay MJ (2008) The C-type lectin surface receptor DCIR acts as a new attachment factor for HIV-1 in dendritic cells and contributes to trans- and cis-infection pathways. Blood 112(4):1299-1307.
10. Meyer-Wentrup F, et al. (2008) Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-alpha production. Blood 111(8):4245-4253.
11. Meyer-Wentrup F, et al. (2009) DCIR is endocytosed into human dendritic cells and inhibits TLR8-mediated cytokine production. J Leukoc Biol 85(3):518-525.
12. Zhao X, et al. (2015) DCIR negatively regulates CpG-ODN-induced IL-1β and IL-6 production. Mol Immunol 68(2 Pt C):641-647.
13. Fujikado N, et al. (2008) Dcir deficiency causes development of autoimmune diseases in mice due to excess expansion of dendritic cells. Nat Med 14(2):176-180.
14. Maruhashi T, et al. (2015) DCIR maintains bone homeostasis by regulating IFN-γ production in T cells. J Immunol 194(12):5681-5691.
15. Seno A, et al. (2015) Exacerbation of experimental autoimmune encephalomyelitis in mice deficient for DCIR, an inhibitory C-type lectin receptor. Exp Anim 64(2):109-119.
16. McNab F, Mayer-Barber K, Sher A, Wack A, O'Garra A (2015) Type I interferons in infectious disease. Nat Rev Immunol 15(2):87-103.
17. Guo J, et al. (2012) A replication study confirms the association of dendritic cell immunoreceptor (DCIR) polymorphisms with ACPA - negative RA in a large Asian cohort. PLoS One 7(7):e41228.
18. Liu M, et al. (2015) Contribution of dendritic cell immunoreceptor (DCIR) polymorphisms in susceptibility of systemic lupus erythematosus and primary Sjogren's syndrome. Hum Immunol 76(11):808-811.
19. Lorentzen JC, et al. (2007) Association of arthritis with a gene complex encoding C-type lectin-like receptors. Arthritis Rheum 56(8):2620-2632.
20. Maglinao M, Klopfleisch R, Seeberger PH, Lepenies B (2013) The C-type lectin receptor DCIR is crucial for the development of experimental cerebral malaria. J Immunol 191(5):2551-2559.
21. Rusinova I, et al. (2013) Interferome v2.0: an updated database of annotated interferon-regulated genes. Nucleic Acids Res 41(Database issue):D1040-D1046.
22. Wu TR, et al. (2002) SHP-2 is a dual-specificity phosphatase involved in Stat1 dephosphorylation at both tyrosine and serine residues in nuclei. J Biol Chem 277(49):47572-47580.
23. You M, Yu DH, Feng GS (1999) Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway. Mol Cell Biol 19(3):2416-2424.
24. Grosskopf S, et al. (2015) Selective inhibitors of the protein tyrosine phosphatase SHP2 block cellular motility and growth of cancer cells in vitro and in vivo. ChemMedChem 10(5):815-826.
25. Szabo SJ, et al. (2000) A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100(6):655-669.
26. Murray PJ, et al. (2014) Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41(1):14-20.
27. McRae BL, Semnani RT, Hayes MP, van Seventer GA (1998) Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development. J Immunol 160(9):4298-4304.
28. de Paus RA, et al. (2013) Inhibition of the type I immune responses of human monocytes by IFN-α and IFN-β. Cytokine 61(2):645-655.
29. McNab FW, et al. (2014) Type I IFN induces IL-10 production in an IL-27-independent manner and blocks responsiveness to IFN-γ for production of IL-12 and bacterial killing in Mycobacterium tuberculosis-infected macrophages. J Immunol 193(7):3600-3612.
30. Lugo-Villarino G, Maldonado-Lopez R, Possemato R, Penaranda C, Glimcher LH (2003) T-bet is required for optimal production of IFN-gamma and antigen-specific T cell activation by dendritic cells. Proc Natl Acad Sci USA 100(13):7749-7754.
31. Richard M, Thibault N, Veilleux P, Gareau-Pagé G, Beaulieu AD (2006) Granulocyte macrophage-colony stimulating factor reduces the affinity of SHP-2 for the ITIM of CLECSF6 in neutrophils: a new mechanism of action for SHP-2. Mol Immunol 43(10):1716-1721.
32. Barrow AD, Trowsdale J (2006) You say ITAM and I say ITIM, let's call the whole thing off: the ambiguity of immunoreceptor signalling. Eur J Immunol 36(7):1646-1653.
33. Desvignes L, Wolf AJ, Ernst JD (2012) Dynamic roles of type I and type II IFNs in early infection with Mycobacterium tuberculosis. J Immunol 188(12):6205-6215.
34. Wiens KE, Ernst JD (2016) The mechanism for type I interferon induction by Mycobacterium tuberculosis is bacterial strain-dependent. PLoS Pathog 12(8):e1005809.
35. Lin PL, et al. (2009) Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model. Infect Immun 77(10):4631-4642.
36. Ritchie ME, et al. (2015) limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43(7):e47.
37. Bolstad BM, Irizarry RA, Astrand M, Speed TP (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19(2):185-193.
38. Suzuki R, Shimodaira H (2006) Pvclust: an R package for assessing the uncertainty in hierarchical clustering. Bioinformatics 22(12):1540-1542.
39. Johnson WE, Li C, Rabinovic A (2007) Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8(1):118-127.
40. Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD (2012) The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 28(6):882-883.
41. Bardou P, Mariette J, Escudié F, Djemiel C, Klopp C (2014) jvenn: an interactive Venn diagram viewer. BMC Bioinformatics 15:293.
42. Spinelli L, Carpentier S, Montañana Sanchis F, Dalod M, Vu Manh TP (2015) Bubble-GUM: automatic extraction of phenotype molecular signatures and comprehensive visualization of multiple Gene Set Enrichment Analyses. BMC Genomics 16(1):814.
43. Subramanian A, Kuehn H, Gould J, Tamayo P, Mesirov JP (2007) GSEA-P: a desktop application for gene set enrichment analysis. Bioinformatics 23(23):3251-3253.
44. Baranek T, et al. (2012) Differential responses of immune cells to type I interferon contribute to host resistance to viral infection. Cell Host Microbe 12(4):571-584.
45. Subramanian A, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102(43):15545-15550.
46. Vérollet C, et al. (2015) HIV-1 reprograms the migration of macrophages. Blood 125(10):1611-1622.